GB8302708D0
(en)
*
|
1983-02-01 |
1983-03-02 |
Efamol Ltd |
Pharmaceutical and dietary composition
|
JPS59172416A
(ja)
*
|
1983-03-18 |
1984-09-29 |
Terumo Corp |
脂肪輸液
|
GB8319073D0
(en)
*
|
1983-07-14 |
1983-08-17 |
Efamol Ltd |
Fatty acid compositions
|
GB8326130D0
(en)
*
|
1983-09-29 |
1983-11-02 |
Efamol Ltd |
Topical preparations containing tars and fatty acids
|
CA1239587A
(en)
*
|
1983-10-24 |
1988-07-26 |
David Rubin |
Combined fatty acid composition for lowering blood cholestrol and triglyceride levels
|
AU4595985A
(en)
*
|
1984-08-10 |
1986-02-13 |
Sentrachem Limited |
Cancer treatment
|
GB8506027D0
(en)
*
|
1985-03-08 |
1985-04-11 |
Efamol Ltd |
Pharmaceutical & dietary compositions
|
GB8507058D0
(en)
*
|
1985-03-19 |
1985-04-24 |
Efamol Ltd |
Pharmaceutical & dietary compositions
|
FR2581310B1
(fr)
*
|
1985-05-02 |
1988-09-23 |
Natura Medica Laboratoires |
Composition therapeutique comportant de l'acide a-linolenique et un compose susceptible de favoriser le passage de l'acide au travers de la membrane cellulaire et extrait de plantes comprenant l'acide et le compose
|
GB8516906D0
(en)
*
|
1985-07-04 |
1985-08-07 |
Efamol Ltd |
Pharmaceutical & dietary composition
|
JPH0648970B2
(ja)
*
|
1985-08-13 |
1994-06-29 |
旭電化工業株式会社 |
無菌油脂組成物の製造法
|
GB8522670D0
(en)
*
|
1985-09-13 |
1985-10-16 |
Efamol Ltd |
Drug treatments
|
GB8524275D0
(en)
*
|
1985-10-02 |
1985-11-06 |
Efamol Ltd |
Pharmaceutical & dietary compositions
|
GB8524276D0
(en)
*
|
1985-10-02 |
1985-11-06 |
Efamol Ltd |
Pharmaceutical & dietary compositions
|
GB8601915D0
(en)
*
|
1986-01-27 |
1986-03-05 |
Efamol Ltd |
Pharmaceutical compositions
|
GB8607137D0
(en)
*
|
1986-03-21 |
1986-04-30 |
Efamol Ltd |
Compositions
|
DE3615710A1
(de)
*
|
1986-05-09 |
1987-11-26 |
Hoechst Ag |
Zubereitungen fuer die synthese von prostaglandinen und hydroxyfettsaeuren in biologischen systemen
|
GB8705459D0
(en)
*
|
1987-03-09 |
1987-04-15 |
Efamol Ltd |
Treatment of peptic ulcers
|
EP0289204B1
(en)
*
|
1987-04-27 |
1991-07-17 |
Efamol Holdings Plc |
Lithium salt-containing pharmaceutical compositions
|
US5252333A
(en)
*
|
1987-04-27 |
1993-10-12 |
Scotia Holdings Plc |
Lithium salt-containing pharmaceutical compositions
|
US5198468A
(en)
*
|
1987-06-24 |
1993-03-30 |
Efamol Holdings Plc |
Essential fatty acid composition
|
GB8714772D0
(en)
*
|
1987-06-24 |
1987-07-29 |
Efamol Ltd |
Essential fatty acid compositions
|
IT1223290B
(it)
*
|
1987-07-27 |
1990-09-19 |
Indena Spa |
Acidi poliinsaturi ad azione vasocinetica e relative formulazioni farmaceutiche e cosmetiche
|
ZA885473B
(en)
*
|
1987-08-07 |
1989-03-29 |
Century Lab Inc |
Free fatty acids for treatment of diabetes mellitus
|
US5034415A
(en)
*
|
1987-08-07 |
1991-07-23 |
Century Laboratories, Inc. |
Treatment of diabetes mellitus
|
DE3734147C2
(de)
*
|
1987-10-09 |
1998-10-29 |
Braun Melsungen Ag |
Isotone omega-3-fettsäurenhaltige Fettemulsion und ihre Verwendung
|
JPH04507397A
(ja)
*
|
1988-01-14 |
1992-12-24 |
フリッツ,アンデルス |
湿疹治療用薬剤製造における必須脂肪酸の使用法
|
GB8806737D0
(en)
*
|
1988-03-22 |
1988-04-20 |
Efamol Holdings |
Therapeutic composition & method
|
US4963368A
(en)
*
|
1988-04-18 |
1990-10-16 |
Nabisco Brands, Inc. |
Oxidoreductase enzyme stabilized highly unsaturated fatty acids and derivatives of such acids
|
GB8813766D0
(en)
*
|
1988-06-10 |
1988-07-13 |
Efamol Holdings |
Essential fatty acid compositions
|
GB8819110D0
(en)
*
|
1988-08-11 |
1988-09-14 |
Norsk Hydro As |
Antihypertensive drug & method for production
|
CA1338683C
(en)
*
|
1988-09-13 |
1996-10-29 |
Efamol Holdings Plc |
Fatty acid therapy and compositions
|
US5059622A
(en)
*
|
1989-08-29 |
1991-10-22 |
Biosyn, Inc. |
Method for reducing blood pressure levels in hypertensive persons
|
DE3901048A1
(de)
*
|
1989-01-14 |
1990-07-19 |
Chimicasa Gmbh |
Antikachectikum
|
US5591446A
(en)
*
|
1989-04-04 |
1997-01-07 |
Beiersdorf, A.G. |
Methods and agents for the prophylaxis of atopy
|
DE3910761A1
(de)
*
|
1989-04-04 |
1990-10-11 |
Bodo Dr Med Melnik |
Mittel zur atopie-prophylaxe
|
ATE135207T1
(de)
*
|
1989-04-04 |
1996-03-15 |
Beiersdorf Ag |
Mittel zur atopieprophylaxe
|
DE3910760A1
(de)
*
|
1989-04-04 |
1990-10-11 |
Bodo Dr Med Melnik |
Neue verwendung bekannter substanzen sowie verfahren zur herstellung von geeigneten praeparaten
|
GB8920228D0
(en)
*
|
1989-09-07 |
1989-10-18 |
Efamol Holdings |
Fatty acid therapy
|
US5407957A
(en)
*
|
1990-02-13 |
1995-04-18 |
Martek Corporation |
Production of docosahexaenoic acid by dinoflagellates
|
US5302617A
(en)
*
|
1990-04-27 |
1994-04-12 |
Kabushikikaisha Ueno Seiyaku Oyo Kenkyuio |
Biochemical treatment with 15-dehydroxy-16-oxoprostaglandin compounds
|
EP0454429B1
(en)
*
|
1990-04-27 |
1997-01-29 |
R-Tech Ueno Ltd. |
Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases
|
GB9012651D0
(en)
*
|
1990-06-06 |
1990-07-25 |
Efamol Holdings |
Essential fatty acid treatment
|
KR100321543B1
(ko)
*
|
1991-01-24 |
2002-09-12 |
마르텍 코포레이션 |
미생물-기원오일혼합물및이의용도
|
GB9111900D0
(en)
*
|
1991-06-03 |
1991-07-24 |
Efamol Holdings |
Fatty acid compositions
|
US5212126A
(en)
*
|
1991-06-10 |
1993-05-18 |
Dresser Industries, Inc. |
Aluminum resistant refractory and method
|
WO1993020717A2
(en)
*
|
1992-04-13 |
1993-10-28 |
Research Corporation Technologies, Inc. |
Reducing gastrointestinal irritation in infant nutrition
|
FR2691616B1
(fr)
*
|
1992-05-27 |
1995-06-09 |
Thorel Jean Noel |
Bio-vecteurs nutritionnels.
|
GB9211229D0
(en)
*
|
1992-05-27 |
1992-07-08 |
Efamol Holdings |
Fatty acid treatment
|
GB9224809D0
(en)
*
|
1992-11-26 |
1993-01-13 |
Scotia Holdings Plc |
Schizophrenia
|
DE4304394A1
(en)
*
|
1993-02-13 |
1993-09-02 |
Fresenius Ag |
Prepn. for nourishment of oncological patients - comprises fats formulation contg. oleic acid, alpha-linolenic acid, etc., and opt. carbohydrate and proteins
|
US20050027004A1
(en)
*
|
1993-06-09 |
2005-02-03 |
Martek Biosciences Corporation |
Methods of treating senile dementia and Alzheimer's diseases using docosahexaenoic acid and arachidonic acid compositions
|
GB9403855D0
(en)
*
|
1994-03-01 |
1994-04-20 |
Scotia Holdings Plc |
Fatty acid derivatives
|
US5952314A
(en)
|
1994-04-01 |
1999-09-14 |
Demichele; Stephen Joseph |
Nutritional product for a person having ulcerative colitis
|
NZ281878A
(en)
*
|
1994-04-01 |
1997-02-24 |
Abbott Lab |
Nutritional product for enteral feeding containing indigestible carbohydrate, an oil blend and optionally protein and other nutrients; used to treat colitis
|
US5780451A
(en)
*
|
1994-04-01 |
1998-07-14 |
Abbott Laboratories |
Nutritional product for a person having ulcerative colitis
|
AU711482B2
(en)
*
|
1994-06-28 |
1999-10-14 |
Scotia Holdings Plc |
Compositions for treatment of diabetic complications
|
JP3770628B2
(ja)
*
|
1994-08-09 |
2006-04-26 |
サントリー株式会社 |
遅延型アレルギー反応を介する医学的症状の予防及び改善剤
|
US5578576A
(en)
*
|
1994-09-02 |
1996-11-26 |
Dalhousie University |
Method and composition for treating intestinal wounds or ulcers
|
EP0711503A3
(en)
*
|
1994-11-14 |
1997-11-26 |
Scotia Holdings Plc |
Milk fortified with GLA and/or DGLA
|
AU5346296A
(en)
|
1995-04-17 |
1996-11-07 |
Japan As Represented By Director-General Of Agency Of Industrial Science And Technology |
Novel microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fa tty acids by using the microorganisms
|
US5962030A
(en)
|
1997-03-07 |
1999-10-05 |
Akesis Pharmaceuticals, Inc. |
Dietary supplement and method of treatment for diabetic control
|
WO1999029317A1
(en)
*
|
1997-12-12 |
1999-06-17 |
Purdue Research Foundation |
Methods and compositions for treating diabetes
|
US7015249B1
(en)
|
1997-12-12 |
2006-03-21 |
Purdue Research Foundation |
Methods and compositions for treating diabetes
|
US7138431B1
(en)
*
|
1998-02-23 |
2006-11-21 |
Wake Forest University |
Dietary control of arachidonic acid metabolism
|
IL125731A
(en)
|
1998-08-11 |
2004-06-20 |
Zvi Yehuda |
Acylates which are products of neurotransmitters and essential fatty acids, pharmaceutical compositions containing them, use of such acylates in the manufacture of medicaments, and method for treating nervous diseases in non-human animals
|
US6376549B1
(en)
*
|
1998-09-17 |
2002-04-23 |
Akesis Pharmaceuticals, Inc. |
Metforimin-containing compositions for the treatment of diabetes
|
US6852760B1
(en)
|
1998-09-17 |
2005-02-08 |
Akesis Pharmaceuticals, Inc. |
Compositions and methods for treatment for glucose metabolism disorders
|
KR20000046633A
(ko)
*
|
1998-12-31 |
2000-07-25 |
성재갑 |
아토피성 피부염 치유용 조성물
|
US6440931B1
(en)
|
1999-02-23 |
2002-08-27 |
Natural Corporation |
Conjugated linoleic acid in treatment and prophylaxis of diabetes
|
WO2001015552A1
(en)
*
|
1999-08-30 |
2001-03-08 |
Ocean Nutrition Canada Ltd. |
A nutritional supplement for lowering serum triglyceride and cholesterol levels
|
US6998501B1
(en)
*
|
1999-08-30 |
2006-02-14 |
Ocean Nutrition Canada Limited |
Nutritional supplement for lowering serum triglyceride and cholesterol levels
|
US6426367B1
(en)
*
|
1999-09-09 |
2002-07-30 |
Efa Sciences Llc |
Methods for selectively occluding blood supplies to neoplasias
|
US6340705B1
(en)
*
|
1999-09-10 |
2002-01-22 |
Monsanto Technology, Llc |
Use of α-linolenic acid metabolites for treatment or prevention of cancer
|
CA2301158A1
(en)
*
|
2000-03-24 |
2001-09-24 |
Stephen J. Allen |
Screening methods for compounds useful for modulating lipid metabolism in disease
|
GB0111282D0
(en)
*
|
2001-05-09 |
2001-06-27 |
Laxdale Ltd |
Potentiation of therapeutic effects of fatty acids
|
JP2004531568A
(ja)
*
|
2001-05-30 |
2004-10-14 |
ラクスデイル リミテッド |
補酵素qおよびエイコサペンタエン酸(epa)
|
GB0113348D0
(en)
|
2001-06-01 |
2001-07-25 |
Mars Uk Ltd |
Skin diet
|
US6853781B2
(en)
*
|
2001-08-13 |
2005-02-08 |
Sumitomo Electric Lightwave Corp. |
Air blown fiber (ABF) cable with low composite coefficient of thermal expansion
|
WO2003017945A2
(en)
*
|
2001-08-24 |
2003-03-06 |
Martek Biosciences Boulder Corporation |
Products containing highly unsaturated fatty acids for use by women and their children during stages of preconception, pregnancy and lactation/post-partum
|
US7098352B2
(en)
*
|
2001-11-16 |
2006-08-29 |
Virtus Nutrition Llc |
Calcium salt saponification of polyunsaturated oils
|
RU2004123792A
(ru)
*
|
2002-01-04 |
2005-04-10 |
Ивэкс Рисеч, Инк. (Us) |
Устройство доставки препарата для пролонгированной доставки глипизита
|
EP1489915A4
(en)
*
|
2002-03-08 |
2005-09-14 |
Monsanto Technology Llc |
TREATMENT AND PREVENTION OF INFLAMMATORY DISORDERS
|
SE0202188D0
(sv)
*
|
2002-07-11 |
2002-07-11 |
Pronova Biocare As |
A process for decreasing environmental pollutants in an oil or a fat, a volatile fat or oil environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
|
EP2295529B2
(en)
|
2002-07-11 |
2022-05-18 |
Basf As |
Use of a volatile environmental pollutants-decreasing working fluid for decreasing the amount of pollutants in a fat for alimentary or cosmetic use
|
US20040208939A1
(en)
*
|
2003-04-18 |
2004-10-21 |
Barry Sears |
Novel dietary compositions to reduce inflammation
|
US7424812B2
(en)
*
|
2003-05-16 |
2008-09-16 |
Stanton Concepts Inc. |
Multiple function lock
|
CA2436650A1
(en)
*
|
2003-08-06 |
2005-02-06 |
Naturia Inc. |
Conjugated linolenic acid (clnatm) compositions: synthesis, purification and uses
|
US7759507B2
(en)
*
|
2003-09-05 |
2010-07-20 |
Abbott Laboratories |
Lipid system and methods of use
|
JP4721642B2
(ja)
*
|
2004-01-20 |
2011-07-13 |
サントリーホールディングス株式会社 |
肝障害を伴う肝臓疾患の予防又は改善剤
|
CA2564592C
(en)
*
|
2004-04-29 |
2013-05-28 |
Abbott Laboratories |
Compositions for improving breast health in women
|
US8663679B2
(en)
|
2004-04-29 |
2014-03-04 |
Abbott Laboratories |
Compositions for improving breast health in women
|
MXPA06013990A
(es)
*
|
2004-04-30 |
2007-08-14 |
Virtus Nutrition Llc |
Sintesis de sal de metal monovalente y divalente de acido graso polinsaturado.
|
US8431165B2
(en)
*
|
2004-12-13 |
2013-04-30 |
Swing Aerobics Licensing, Inc. |
Medicament for treatment of cancer and other diseases
|
US8092839B2
(en)
*
|
2004-12-13 |
2012-01-10 |
Swing Aerobics Licensing, Inc. |
Medicament for treatment of cancer and other diseases
|
JP2006306812A
(ja)
*
|
2005-04-28 |
2006-11-09 |
Suntory Ltd |
好酸球浸潤抑制剤
|
EP1852114B1
(en)
|
2005-02-14 |
2019-09-18 |
Suntory Holdings Limited |
Composition containing dihomo-y-linolenic acid (dgla) as active ingredient
|
JP2006306813A
(ja)
*
|
2005-04-28 |
2006-11-09 |
Suntory Ltd |
肥満細胞増殖抑制剤
|
US20070154498A1
(en)
*
|
2005-12-09 |
2007-07-05 |
Bortz Jonathan D |
Intravenous essential fatty acid emulsion
|
US8343753B2
(en)
*
|
2007-11-01 |
2013-01-01 |
Wake Forest University School Of Medicine |
Compositions, methods, and kits for polyunsaturated fatty acids from microalgae
|
US9006288B2
(en)
*
|
2009-01-12 |
2015-04-14 |
Biokier, Inc. |
Composition and method for treatment of diabetes
|
JP5715070B2
(ja)
|
2009-02-16 |
2015-05-07 |
ノグラ ファーマ リミテッド |
アルキルアミド化合物およびその使用
|
GB0907413D0
(en)
|
2009-04-29 |
2009-06-10 |
Equateq Ltd |
Novel methods
|
CN102370720A
(zh)
*
|
2010-08-27 |
2012-03-14 |
翟长民 |
治疗鼻炎用脱敏膏
|
US8293790B2
(en)
|
2011-10-19 |
2012-10-23 |
Dignity Sciences Limited |
Pharmaceutical compositions comprising DGLA and benzoyl peroxide and methods of use thereof
|
JP6301844B2
(ja)
|
2012-02-09 |
2018-03-28 |
ノグラ ファーマ リミテッド |
線維症の処置方法
|
CN102641370A
(zh)
*
|
2012-05-02 |
2012-08-22 |
李承平 |
一种治疗鼻炎的药物组合软膏
|
KR102391827B1
(ko)
|
2014-06-04 |
2022-04-27 |
디에스 바이오파마 리미티드 |
Dgla를 포함하는 약제학적 조성물 및 그의 용도
|
EP3399971A1
(en)
*
|
2016-01-07 |
2018-11-14 |
DS Biopharma Limited |
Pharmaceutical compositions comprising dgla and use of same
|
WO2017144725A1
(en)
*
|
2016-02-26 |
2017-08-31 |
Nogra Pharma Limited |
Methods of treating lactose intolerance
|
MX2018013727A
(es)
*
|
2016-05-11 |
2019-08-29 |
Univ Southern California |
Dieta imitadora del ayuno (fmd) como un tratamiento inmunoregulador para enfermedades gastrointestinales autoinmunes/inflamatorias.
|
US10639313B2
(en)
|
2017-09-01 |
2020-05-05 |
Ndsu Research Foundation |
Compound for inhibition of delta-5-desaturase (D5D) and treatment of cancer and inflammation
|
US11905232B2
(en)
|
2019-02-08 |
2024-02-20 |
Nogra Pharma Limited |
Process of making 3-(4′-aminophenyl)-2-methoxypropionic acid, and analogs and intermediates thereof
|